These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics. Zhang M; Cheng S; Jin Y; Zhang N; Wang Y Clin Transl Med; 2021 Feb; 11(2):e292. PubMed ID: 33635002 [TBL] [Abstract][Full Text] [Related]
3. The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Li B; Wang F; Gui L; He Q; Yao Y; Chen H Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404 [TBL] [Abstract][Full Text] [Related]
4. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine. Rosso G; Cauda V ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896 [TBL] [Abstract][Full Text] [Related]
5. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications. Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403 [TBL] [Abstract][Full Text] [Related]
6. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles. Bai YT; Zhang XQ; Chen XJ; Zhou G Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844 [TBL] [Abstract][Full Text] [Related]
7. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics. Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250 [TBL] [Abstract][Full Text] [Related]
9. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930 [TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications. Wang C; Zhang Y; Dong Y Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124 [TBL] [Abstract][Full Text] [Related]
11. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges. Syn NL; Wang L; Chow EK; Lim CT; Goh BC Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132 [TBL] [Abstract][Full Text] [Related]
12. Advances in Engineering Cells for Cancer Immunotherapy. Xu X; Li T; Shen S; Wang J; Abdou P; Gu Z; Mo R Theranostics; 2019; 9(25):7889-7905. PubMed ID: 31695806 [TBL] [Abstract][Full Text] [Related]
13. REMEDIAL APPLICATIONS OF EXOSOMES IN CANCER, INFECTIONS AND DIABETES. Wang Q; Ding X; Zhen F; Ma J; Meng F Acta Pol Pharm; 2017 Mar; 74(2):313-320. PubMed ID: 29624236 [TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation. Burnouf T; Agrahari V; Agrahari V Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783 [TBL] [Abstract][Full Text] [Related]
15. Exosomes: Powerful weapon for cancer nano-immunoengineering. Pi YN; Xia BR; Jin MZ; Jin WL; Lou G Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines. Kotmakçı M; Bozok Çetintaş V J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135 [TBL] [Abstract][Full Text] [Related]